Literature DB >> 15285776

Factors of importance for weight loss in elderly patients with Parkinson's disease.

B Lorefält1, W Ganowiak, S Pålhagen, G Toss, M Unosson, A-K Granérus.   

Abstract

OBJECTIVE: Weight loss is reported frequently in patients with Parkinson's disease (PD). The objective of this study was to find the underlying factors of this phenomenon. PARTICIPANTS AND METHODS: Twenty-six L-dopa-treated patients with PD and 26 age- and sex-matched healthy controls were assessed twice within a 1-year interval. Body weight, body fat mass, resting energy expenditure, physical activity, energy intake, thyroid hormones and cognitive function were investigated.
RESULTS: Nineteen (73%) of the PD patients lost body weight, although energy intake and the time for rest increased. Weight loss was most marked in patients with more severe PD symptoms and in whom cognitive function had decreased. Multiple regression analyses showed that determinants for weight loss were female gender, age and low physical activity.
CONCLUSION: Weight loss was common in PD patients, in spite of the increased energy intake and was most obvious in patients with increased PD symptoms and decreased cognitive function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15285776     DOI: 10.1111/j.1600-0404.2004.00307.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  31 in total

1.  Ghrelin antagonized 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells.

Authors:  Juanjuan Dong; Ning Song; Junxia Xie; Hong Jiang
Journal:  J Mol Neurosci       Date:  2008-12-04       Impact factor: 3.444

Review 2.  Musculoskeletal problems in Parkinson's disease.

Authors:  Young Eun Kim; Beom S Jeon
Journal:  J Neural Transm (Vienna)       Date:  2013-02-19       Impact factor: 3.575

3.  The nutritional status of Dutch elderly patients with Parkinson's disease.

Authors:  J van Steijn; B van Harten; E Flapper; E Droogsma; P van Walderveen; M Blaauw; D van Asselt
Journal:  J Nutr Health Aging       Date:  2014       Impact factor: 4.075

4.  Bone mineral density and vitamin D status in Parkinson's disease patients.

Authors:  F van den Bos; A D Speelman; M van Nimwegen; Y T van der Schouw; F J G Backx; B R Bloem; M Munneke; H J J Verhaar
Journal:  J Neurol       Date:  2012-10-09       Impact factor: 4.849

5.  Nutritional status and health care costs for the elderly living in municipal residential homes--an intervention study.

Authors:  B Lorefält; A Andersson; A B Wirehn; S Wilhelmsson
Journal:  J Nutr Health Aging       Date:  2011-02       Impact factor: 4.075

6.  The relationship between clinical phenotype and early staged bilateral deep brain stimulation in Parkinson disease.

Authors:  Victor W Sung; Ray L Watts; Christian J Schrandt; Stephanie Guthrie; Deli Wang; Amy W Amara; Barton L Guthrie; Harrison C Walker
Journal:  J Neurosurg       Date:  2013-09-27       Impact factor: 5.115

7.  Influences of levodopa on adipose tissue and skeletal muscle metabolism in patients with idiopathic Parkinson's disease.

Authors:  Frauke Adams; Michael Boschmann; Elmar Lobsien; Andreas Kupsch; Axel Lipp; Gabriele Franke; Marie Charlotte Leisse; Juergen Janke; Simone Gottschalk; Joachim Spranger; Jens Jordan
Journal:  Eur J Clin Pharmacol       Date:  2008-07-30       Impact factor: 2.953

8.  Metabolic abnormalities and hypoleptinemia in α-synuclein A53T mutant mice.

Authors:  Sarah M Rothman; Kathleen J Griffioen; Kenneth W Fishbein; Richard G Spencer; Sokratis Makrogiannis; Wei-Na Cong; Bronwen Martin; Mark P Mattson
Journal:  Neurobiol Aging       Date:  2013-10-22       Impact factor: 4.673

9.  Nutritional status in Parkinson's disease patients undergoing deep brain stimulation surgery: a pilot study.

Authors:  J M Sheard; S Ash; P A Silburn; G K Kerr
Journal:  J Nutr Health Aging       Date:  2013-02       Impact factor: 4.075

10.  Nutritional therapies in Parkinson's disease.

Authors:  Marian L Evatt
Journal:  Curr Treat Options Neurol       Date:  2007-05       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.